HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajit P Limaye Selected Research

Fungemia

1/2017Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.
11/2010Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients.
1/2010Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis.
12/2009Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis.
1/2008Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen.
3/2007Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality.
8/2006Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection.
10/2005Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajit P Limaye Research Topics

Disease

26Infections
09/2022 - 01/2002
9Viremia
01/2022 - 03/2005
9Cryptococcosis
11/2010 - 10/2005
8Fungemia
01/2017 - 10/2005
5Critical Illness (Critically Ill)
11/2021 - 07/2008
5Cytomegalovirus Infections (Inclusion Disease)
08/2021 - 01/2002
5Hepatitis C
01/2019 - 01/2017
4COVID-19
12/2021 - 07/2020
4Renal Insufficiency (Renal Failure)
09/2010 - 02/2006
3Virus Diseases (Viral Diseases)
01/2022 - 01/2017
3Sepsis (Septicemia)
01/2021 - 06/2015
3Pneumonia (Pneumonitis)
01/2019 - 02/2016
3Human Influenza (Influenza)
01/2019 - 10/2018
3Late Onset Disorders
01/2019 - 01/2010
3Aspergillosis
12/2015 - 02/2006
2Lymphopenia (Lymphocytopenia)
12/2020 - 03/2007
2Disease Progression
01/2020 - 02/2003
2Opportunistic Infections (Opportunistic Infection)
01/2020 - 06/2010
2Invasive Fungal Infections
12/2015 - 12/2006
2Latent Tuberculosis
01/2014 - 11/2013
1Tenosynovitis
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
12/2020
1Bronchiolitis Obliterans Syndrome
11/2020
1Hypersensitivity (Allergy)
10/2020
1Fibrosis (Cirrhosis)
01/2020
1Hemorrhagic Cystitis
01/2020
1Neutropenia
01/2020
1Herpes Zoster
01/2019
1Laboratory Infection
01/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Chickenpox
01/2019
1Adenoviridae Infections (Adenovirus Infections)
01/2018
1Bacteremia
01/2017
1Hepatitis B
01/2017
1Wounds and Injuries (Trauma)
01/2017
1Persistent Infection
01/2016
1Burns
07/2015
1Tuberculosis (Tuberculoses)
11/2013
1Coccidioidomycosis
03/2013
1Acanthamoeba Keratitis
08/2012
1Eye Infections
08/2012

Drug/Important Bio-Agent (IBA)

11Antiviral Agents (Antivirals)IBA
01/2022 - 01/2002
6ValganciclovirFDA Link
01/2022 - 06/2010
4Interleukin-10 (Interleukin 10)IBA
01/2019 - 08/2006
4Ganciclovir (Cytovene)FDA LinkGeneric
01/2017 - 01/2002
3Pharmaceutical PreparationsIBA
09/2022 - 12/2015
3Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 06/2015
3N-acetyltalosaminuronic acid (NAT)IBA
01/2019 - 11/2017
3AntigensIBA
01/2010 - 01/2008
3Calcineurin InhibitorsIBA
12/2009 - 03/2007
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2008 - 08/2006
2Tacrolimus (Prograf)FDA LinkGeneric
01/2021 - 08/2006
2AutoantigensIBA
11/2020 - 01/2020
2CytokinesIBA
01/2019 - 08/2006
2AntibodiesIBA
01/2019 - 08/2006
2InterferonsIBA
11/2013 - 03/2007
2Amphotericin B (Amphotericin)FDA LinkGeneric
12/2009 - 10/2005
2LipidsIBA
12/2009 - 02/2006
2Antifungal AgentsIBA
02/2008 - 10/2005
2Cidofovir (Vistide)FDA Link
03/2005 - 02/2003
1B7-H1 AntigenIBA
01/2022
1letermovirIBA
08/2021
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2021
1Ribavirin (Virazole)FDA LinkGeneric
12/2020
1presatovirIBA
12/2020
1TubulinIBA
11/2020
1Collagen Type V (Type V Collagen)IBA
11/2020
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2020
1LactamsIBA
10/2020
1Viral AntigensIBA
01/2020
1cyclo(Arg-Pro) (CI 4)IBA
01/2020
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2020
1Interferon-gamma (Interferon, gamma)IBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1InterleukinsIBA
01/2019
1Hemagglutinins (Hemagglutinin)IBA
01/2019
1Interleukin-4 (Interleukin 4)IBA
01/2019
1Interleukin-13IBA
01/2019
1VaccinesIBA
10/2018
1CreatinineIBA
01/2018
1Nucleic AcidsIBA
11/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1IA 3 (IA-3)IBA
12/2015
1Isoniazid (Ftivazide)FDA LinkGeneric
01/2014
1rifapentine (Priftin)FDA Link
01/2014
1Tuberculin (PPD)IBA
11/2013
1SolutionsIBA
08/2012

Therapy/Procedure

17Transplantation
09/2022 - 01/2002
13Therapeutics
01/2021 - 01/2002
12Liver Transplantation
11/2021 - 12/2006
6Organ Transplantation
01/2021 - 04/2011
2Mechanical Ventilators (Ventilator)
01/2021 - 01/2017
2Lung Transplantation
01/2020 - 06/2010
2Length of Stay
01/2017 - 07/2008
2Artificial Respiration (Mechanical Ventilation)
01/2017 - 07/2015
1Donor Selection
07/2020
1Cell Transplantation
01/2020
1Hematopoietic Stem Cell Transplantation
01/2020
1Contact Lenses
08/2012
1Drug Therapy (Chemotherapy)
08/2012